ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Faculty Opinions recommendation of A randomized phase II study of immunization with dendritic cells modified with poxvectors encoding CEA and MUC1 compared with the same poxvectors plus GM-CSF for resected metastatic colorectal cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.718016078.793485778
◽
2013
◽
Author(s):
Kellie Mathis
Keyword(s):
Colorectal Cancer
◽
Dendritic Cells
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Gm Csf
◽
Randomized Phase Ii
Download Full-text
Related Documents
Cited By
References
A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastatic Colorectal Cancer
Annals of Surgery
◽
10.1097/sla.0b013e318292919e
◽
2013
◽
Vol 258
(6)
◽
pp. 879-886
◽
Cited By ~ 77
Author(s):
Michael A. Morse
◽
Donna Niedzwiecki
◽
John L. Marshall
◽
Christopher Garrett
◽
David Z. Chang
◽
...
Keyword(s):
Colorectal Cancer
◽
Dendritic Cells
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Gm Csf
◽
Randomized Phase Ii
Download Full-text
Randomized phase II study of FOLFIRI plus ramucirumab (Rmab) versus FOLFOXIRI plus Rmab as first-line treatment for patients with metastatic colorectal cancer (mCRC): WJOG9216G
Annals of Oncology
◽
10.1093/annonc/mdy281.151
◽
2018
◽
Vol 29
◽
pp. viii201
Author(s):
Y. Kito
◽
T. Yamada
◽
T. Matsumoto
◽
H. Yasui
◽
K. Murata
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Line Treatment
◽
First Line
◽
Randomized Phase Ii
◽
First Line Treatment
Download Full-text
5-Fluorouracil Administered as a 48-Hour Chronomodulated Infusion in Combination with Leucovorin and Cisplatin: A Randomized Phase II Study in Metastatic Colorectal Cancer
Oncology
◽
10.1159/000055349
◽
2001
◽
Vol 61
(1)
◽
pp. 28-35
◽
Cited By ~ 8
Author(s):
Alfredo Falcone
◽
Giacomo Allegrini
◽
Gianluca Masi
◽
Monica Lencioni
◽
Elisabetta Pfanner
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Randomized Phase Ii
Download Full-text
Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study)
Medical Oncology
◽
10.1007/s12032-019-1254-4
◽
2019
◽
Vol 36
(6)
◽
Cited By ~ 1
Author(s):
Naoki Nagata
◽
Hiromichi Maeda
◽
Keiichiro Ishibashi
◽
Keiji Hirata
◽
Akitaka Makiyama
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Second Line
◽
Wild Type
◽
Open Label
◽
Randomized Phase Ii
Download Full-text
Final results of a randomized phase II study of perifosine in combination with capecitabine (P-CAP) versus placebo plus capecitabine (CAP) in patients (pts) with second- or third-line metastatic colorectal cancer (mCRC).
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.3531
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. 3531-3531
◽
Cited By ~ 4
Author(s):
D. A. Richards
◽
J. J. Nemunaitis
◽
S. J. Vukelja
◽
C. T. Hagenstad
◽
L. T. Campos
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Randomized Phase Ii
◽
Third Line
Download Full-text
PEAK: A randomized phase II study to compare the efficacy of panitumumab plus mFOLFOX6 to bevacizumab plus mFOLFOX6 in patients (pts) with previously untreated, unresectable metastatic colorectal cancer (mCRC) expressing wild-type KRAS.
Journal of Clinical Oncology
◽
10.1200/jco.2010.28.15_suppl.tps189
◽
2010
◽
Vol 28
(15_suppl)
◽
pp. TPS189-TPS189
Author(s):
L. S. Schwartzberg
◽
V. J. Wagner
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Wild Type
◽
Randomized Phase Ii
◽
Unresectable Metastatic Colorectal Cancer
Download Full-text
Randomized phase II study of regorafenib followed by cetuximab versus reverse sequence for wild-type KRAS metastatic colorectal cancer previously treated with fluoropyrimidine, oxaliplatin, and irinotecan (REVERCE).
Journal of Clinical Oncology
◽
10.1200/jco.2014.32.15_suppl.tps3662
◽
2014
◽
Vol 32
(15_suppl)
◽
pp. TPS3662-TPS3662
Author(s):
Kohei Shitara
◽
Kentaro Yamazaki
◽
Hiroyuki Uetake
◽
Takeshi Kato
◽
Eiji Oki
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Wild Type
◽
Randomized Phase Ii
◽
Reverse Sequence
◽
Previously Treated
Download Full-text
A randomized phase II study (B2151005) of the intravenous phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor PF-05212384 plus irinotecan versus cetuximab plus irinotecan in patients with wild-type KRAS metastatic colorectal cancer (mCRC).
Journal of Clinical Oncology
◽
10.1200/jco.2014.32.15_suppl.tps3649
◽
2014
◽
Vol 32
(15_suppl)
◽
pp. TPS3649-TPS3649
◽
Cited By ~ 2
Author(s):
Josep Tabernero
◽
Nicoletta Brega
◽
Craig Davis
◽
Ashwin Gollerkeri
◽
Kristen Pierce
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Mtor Inhibitor
◽
Phase Ii Study
◽
Mammalian Target Of Rapamycin
◽
Target Of Rapamycin
◽
Wild Type
◽
Phosphatidylinositol 3 Kinase
◽
Randomized Phase Ii
Download Full-text
Persistent prevention of CIPN using calmangafodipir (PledOx): Results from a placebo-controlled randomized phase II study (PLIANT) in patients with metastatic colorectal cancer (mCRC).
Journal of Clinical Oncology
◽
10.1200/jco.2016.34.15_suppl.10018
◽
2016
◽
Vol 34
(15_suppl)
◽
pp. 10018-10018
◽
Cited By ~ 2
Author(s):
Bengt Glimelius
◽
Nebojsa Manojlovic
◽
Per Pfeiffer
◽
Baadur Mosidze
◽
Galina Petrova Kurteva
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Randomized Phase Ii
Download Full-text
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial
Clinical Colorectal Cancer
◽
10.1016/j.clcc.2018.03.001
◽
2018
◽
Vol 17
(3)
◽
pp. 231-239.e7
◽
Cited By ~ 13
Author(s):
Derek J. Jonker
◽
Patricia A. Tang
◽
Hagen Kennecke
◽
Stephen A. Welch
◽
M. Christine Cripps
◽
...
Keyword(s):
Colorectal Cancer
◽
Metastatic Colorectal Cancer
◽
Phase Ii
◽
Phase Ii Study
◽
Randomized Phase Ii
◽
Cancer Trials
◽
Group Trial
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close